We are live on ! Find out more
RCPI

ROCK CREEK PHARMACEUTICALS INC COM STK (DE)
RCPI

Delisted

RCPI was delisted on the 4th of November, 2015.

Back to rankings

9 hedge funds and large institutions have $203K invested in ROCK CREEK PHARMACEUTICALS INC COM STK (DE) in 2015 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed

73% less capital invested

Capital invested by funds: $751K → $203K (-$548K)

76% less funds holding

Funds holding: 37 → 9 (-28)

90% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 31

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $3K

Holders
9
Holders Change
-28
Holders Change %
-75.68%
% of All Funds
0.24%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
–
Reduced
1
Closed
31
Calls
–
Puts
$3K
Net Calls
-$3K
Net Calls Change
+$4K

Top Buyers

Rank Fund Capital Flow
1
KCM
Kempner Capital Management
Texas
+$97.3K

Top Sellers

Rank Fund Capital Flow
1
BIT
BlackRock Institutional Trust
California
-$163K
2
Vanguard Group
Vanguard Group
Pennsylvania
-$155K
3
TCM
Tenor Capital Management
New York
-$94K
4
TC
Talkot Capital
California
-$62K
5
VKH
Virtu KCG Holdings
New York
-$26K
Name Holding Trade Value Shares
Change 		Change in
Stake
Ameriprise
1
Ameriprise
Minnesota
$121K -$14.9K -16,780 -9%
KCM
2
Kempner Capital Management
Texas
$80K +$97.3K +109,600 New
WP
3
WealthPLAN Partners
Nebraska
$1.41K +$1.72K +1,936 New
IWMPD
4
Integrated Wealth Management (Palm Desert)
California
$1K – – –
BIT
5
BlackRock Institutional Trust
California
– -$163K -198,937 Closed
Vanguard Group
6
Vanguard Group
Pennsylvania
– -$155K -188,908 Closed
TCM
7
Tenor Capital Management
New York
– -$94K -115,011 Closed
TC
8
Talkot Capital
California
– -$62K -75,291 Closed
Geode Capital Management
9
Geode Capital Management
Massachusetts
– -$25K -31,699 Closed
VKH
10
Virtu KCG Holdings
New York
– -$26K -31,116 Closed
Citadel Advisors
11
Citadel Advisors
Florida
– -$25K -30,559 Closed
TRCT
12
Tower Research Capital (TRC)
New York
– -$15K -18,116 Closed
Morgan Stanley
13
Morgan Stanley
New York
– -$11K -13,706 Closed
Northern Trust
14
Northern Trust
Illinois
– -$11K -13,346 Closed
CCS
15
Crosspoint Capital Strategies
California
– -$6K -7,580 Closed
BA
16
BlackRock Advisors
Delaware
– -$2K -3,008 Closed
UBS Group
17
UBS Group
Switzerland
– -$2K -2,362 Closed
LWCFA
18
Loring Wolcott & Coolidge Fiduciary Advisors
Massachusetts
– -$3K -2,000 Closed
IA
19
IFP Advisors
Florida
– +$263 +296 New

RCPI Hedge Fund Activity: Q4 2015 in Review

9 of the 3,813 institutional investors tracked by Wall St. Rank reported a position in ROCK CREEK PHARMACEUTICALS INC COM STK (DE) (RCPI) for Q4 2015, worth a combined $203K — down 73% from $751K a quarter earlier.

Sellers outnumbered buyers: 31 funds closed out of RCPI and 3 opened new positions — a net loss of 28 holders — while 1 trimmed existing stakes and 0 added.

The largest buyer was Kempner Capital Management, opening a new position worth an estimated $97.3K. The largest seller was BlackRock Institutional Trust, exiting entirely with an estimated $163K sold.

  • 9 institutional investors held ROCK CREEK PHARMACEUTICALS INC COM STK (DE) (RCPI) as of Q4 2015, down from 37 in Q3 2015.
  • Funds reported $203K of ROCK CREEK PHARMACEUTICALS INC COM STK (DE) stock for Q4 2015, down 73% quarter-over-quarter.
  • 3 funds opened new ROCK CREEK PHARMACEUTICALS INC COM STK (DE) positions in Q4 2015 and 31 closed out, a net change of -28 holders.
  • The largest ROCK CREEK PHARMACEUTICALS INC COM STK (DE) buyer in Q4 2015 was Kempner Capital Management, an estimated $97.3K added.
  • The largest ROCK CREEK PHARMACEUTICALS INC COM STK (DE) seller in Q4 2015 was BlackRock Institutional Trust, an estimated $163K sold.

Based on aggregated 13F filings for Q4 2015.